<?xml version="1.0" encoding="UTF-8"?>
<p>Currently, the most widely studied antiviral agents against coronaviruses are remdesivir, ribavirin, lopinavir, ritonavir, and interferon beta. Ribavirin, used alone, has had no demonstrated effect against SARS. When combined with lopinavir, plus rotinavir and a corticosteroid and given to patients infected with SARS, those treated were less likely to develop ARDS, and death rates were lower than those treated with ribavirin and a corticosteroid [
 <xref ref-type="bibr" rid="CR1">1</xref>].
</p>
